Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Bull: Accelerated transition to clean energy (hydrogen, carbon capture) drives higher-than-expected project backlogs.
Cyclical Multiple Reversion: Market abruptly shifts pricing paradigm from 'secular compounder' to 'industrial cyclical', crushing the >25x multiple down to a historical 15x average.
Linde is a dominant player in the highly consolidated global industrial gas market. The business benefits from high barriers to entry, localized economies of density, and long-term take-or-pay contracts. These factors provide strong pricing power and stable cash generation, helping to insulate the company from the broader cyclicality of its end markets (manufacturing, metals, chemicals).
Linde is a dominant player in the highly consolidated global industrial gas market. The business benefits from high barriers to entry, localized economies of density, and long-term take-or-pay contracts. These factors provide strong pricing power and stable cash generation, helping to insulate the company from the broader cyclicality of its end markets (manufacturing, metals, chemicals).
Secular energy transition optimism and continuous pricing power drive unconstrained multiple expansion.
Sell. The risk of multiple compression to historical cyclical norms presents unacceptable downside exposure.
Linde plc operates as an industrial gas company worldwide. It offers atmospheric gases, including oxygen, nitrogen, argon, and rare gases; and process gases, such as hydrogen, helium, carbon dioxide, carbon monoxide, electronic gases, specialty gases, and acetylene. The company also engages in designing and constructing of turnkey process plants for third-party customers, as well as for the gas businesses in various locations comprising air separation, hydrogen, synthesis, olefin, and natural gas plants. It serves healthcare, chemicals and energy, manufacturing, metals and mining, food and beverage, and electronics industries. The company operates in the United States, Brazil, Mexico, Canada, Germany, the Unted Kingdom, Eastern Europe, China, Australia, South Korea, And India. Linde plc was founded in 1879 and is based in Woking, the United Kingdom.
A rapid normalization of Linde's terminal multiple from ~25x to our 15x cyclical baseline, paired with a global industrial recession. High capital intensity limits downside cash flow flexibility, dragging FCFF intrinsic value down to the $234 level.
Highly consolidated market structure, highly localized economies of density, and decades-long take-or-pay contracts.
Economic profit is supported when reported returns exceed the company cost-of-capital hurdle.
Unavailable
FCFF DCF remains positive at the base case: base FCFF $5.8B after capex $5.2B, with terminal value at 62.6% of enterprise value. No FCF cliff is projected unless capex/ or materially resets.
Accelerated transition to clean energy (hydrogen, carbon capture) drives higher-than-expected project backlogs. Sustained allows for continued expansion, while healthcare and electronics end-markets drive secular volume growth.
If baseline revenue growth holds above 5%, maintain current base valuations. If capex to D&A spikes above 1.5x, aggressively downgrade FCFF targets.
If baseline revenue growth holds above 5%, maintain current base valuations. If capex to D&A spikes above 1.5x, aggressively downgrade FCFF targets.
Enduring heavy reinvestment phase (Capex/D&A > 1.4x) required to maintain the footprint, masking a drag on true cash generation.
Secular energy transition optimism and continuous pricing power drive unconstrained multiple expansion.
Industrial volume contraction and aggressive multiple compression reverting to standard cyclical norms.
Enduring heavy reinvestment phase (Capex/D&A > 1.4x) required to maintain the footprint, masking a drag on true cash generation.
Zero weight. Immediate divestiture recommended.
Liquidate all existing positions immediately. The asymmetric risk profile features a near 44% downside gap to our intrinsic value midpoint.
Upside case depends on the report valuation range and named growth catalysts.
We initiate a sell rating. The market drastically misprices LIN as a secular compounder. Fair value range: {"low":208.99,"mid":276.69,"high":355.92,"currency":"USD"}. Applying a normalized cyclical playbook with a 15x terminal multiple exposes extreme downside risk.
LIN is rated Sell at $493.16 versus the reconciled fair value midpoint of $276.69, implying -43.89% upside/downside.
At $493.16, the stock is measured against the final $276.69 midpoint and -43.89% upside/downside, so new capital should respect the report margin-of-safety discipline.
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
A deep, prolonged global industrial recession severely impacts base volumes. Simultaneously, higher interest rates or persistent inflation constrain returns on newly deployed capital, limiting value creation from green energy transitions.
Market abruptly shifts pricing paradigm from 'secular compounder' to 'industrial cyclical', crushing the >25x multiple down to a historical 15x average.
Prolonged global manufacturing and metals recession drives base volumes down, completely offsetting the downside protection of take-or-pay minimums.
Accelerated clean energy investments require structurally higher capex without commensurate return on invested capital, impairing FCFF generation.
The five developments that would weaken our investment case.
Weakening cash conversion relative to reported net income indicates capital allocation friction or delayed customer collections, restricting the internal funding required for high-capex growth initiatives.
Current:1.5 as of 2026-05-08
Alert ifFalls below 1.0x over any trailing twelve-month period
Weakening contract renewal pricing and take-or-pay terms directly compress operating profitability, undermining the structural cash flow stability that justifies Linde's valuation premium.
Current:27.2% for the period ended 2025-12-31
Alert ifContracts below 22.0% across two consecutive quarters
A deep industrial slowdown that contracts top-line volumes overwhelms take-or-pay baseline protections, exposing the business to cyclical end-market downturns across metals, chemicals, and manufacturing.
Current:3.0% for the period ended 2025-12-31
Alert ifTurns negative below 0.0% over two consecutive fiscal quarters
A severe drop in gross profitability would indicate that localized density advantages and pricing power are failing to offset escalating production and energy costs, eroding core earnings power.
Current:48.8% for the period ended 2025-12-31
Alert ifFalls below 40.0% over any trailing twelve-month period
Unproductive capital deployment into clean energy and hydrogen projects without matching returns would dilute capital efficiency, impairing future free cash flow generation and compounding capacity.
Current:11.2% as of 2026-05-08
Alert ifDeclines below 9.0% on an annualized basis
Each lens answers a different valuation question. Only included lenses set Fair value; floors and diagnostics provide context.
Apply a terminal P/E to the dated forward EPS path, then discount that future share value back to the analysis date.
Convert the revenue and margin path into after-tax free cash flow, discount the annual per-share amounts and at , then adjust for signed per current share.
Add depreciation to net income, subtract maintenance capex, divide by diluted shares, and apply a normalized valuation multiple.
Our baseline enforces a strict cyclical playbook, capping terminal multiples at 15x. Stable cash flows are recognized but heavily offset by necessary capital expenditures to maintain the highly localized industrial gas network.
If baseline revenue growth holds above 5%, maintain current base valuations. If capex to D&A spikes above 1.5x, aggressively downgrade FCFF targets.
If baseline revenue growth holds above 5%, maintain current base valuations. If capex to D&A spikes above 1.5x, aggressively downgrade FCFF targets.
Warning level: Falls below 1.0x over any trailing twelve-month period. Weakening cash conversion relative to reported net income indicates capital allocation friction or delayed customer collections, restricting the internal funding required for high-capex growth initiatives.
Warning level: Contracts below 22.0% across two consecutive quarters. Weakening contract renewal pricing and take-or-pay terms directly compress operating profitability, undermining the structural cash flow stability that justifies Linde's valuation premium.
Warning level: Turns negative below 0.0% over two consecutive fiscal quarters. A deep industrial slowdown that contracts top-line volumes overwhelms take-or-pay baseline protections, exposing the business to cyclical end-market downturns across metals, chemicals, and manufacturing.
Warning level: Falls below 40.0% over any trailing twelve-month period. A severe drop in gross profitability would indicate that localized density advantages and pricing power are failing to offset escalating production and energy costs, eroding core earnings power.
Warning level: Declines below 9.0% on an annualized basis. Unproductive capital deployment into clean energy and hydrogen projects without matching returns would dilute capital efficiency, impairing future free cash flow generation and compounding capacity.
| — |
| $33.36B |
| $32.85B |
| $33.01B |
| $33.99B |
| +0.6% |
| Gross profit | — | $13.91B | $15.36B | $15.86B | $16.60B | +6.1% |
| Operating income | — | $5.76B | $8.40B | $9.06B | $9.36B | +17.6% |
| Net income | — | $4.15B | $6.20B | $6.57B | $6.90B | +18.5% |
| EPS (diluted) | $7.33 | $8.23 | $12.59 | $13.62 | $14.61 | +18.8% |
| EBITDA | — | $9.96B | $12.22B | $12.84B | $13.12B | +9.6% |
| R&D | — | $143.0M | $146.0M | $150.0M | $147.0M | +0.9% |
| SG&A | — | $3.11B | $3.30B | $3.34B | $3.43B | +3.4% |
Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.
| Revenue | 33,986,000,000 |
|---|---|
| Cost of revenue | 17,389,000,000 |
| Gross profit | 16,597,000,000 |
| Operating expenses | 7,343,000,000 |
| Operating income | 9,254,000,000 |
| Non-operating items and tax | -2,356,000,000 |
| Net income | 6,898,000,000 |
Point-in-time financial data used in the 2026-05-08 analysis.
| Period | Revenue | EBITDA | Net income | Operating cash flow | Free cash flow | Capex | Depreciation and amortization | Stock-based compensation | Share repurchases | Dividends paid | Net debt issuance | Investing cash flow | Financing cash flow | Beginning cash | Ending cash | Cash and investments | Total debt | Operating margin | ROIC | WACC | ROIC − WACC spread |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | 33.4B | 10B | 4.1B | 8.9B | 5.7B | 3.2B | 4.2B | 107M | 5.2B | 2.3B | 4.5B | — | — | — | — | 5.4B | 18.8B | 19.4% | — | — | — |
| 2023-12-31 | 32.9B | 12.2B | 6.2B | 9.3B | 5.5B | 3.8B | 3.8B | 141M | 4B | 2.5B | 1.1B | — | — | — | — | 4.7B | 20.3B | 24.7% | — | 7.6% | — |
| 2024-12-31 | 33B | 12.8B | 6.6B | 9.4B | 4.9B | 4.5B | 3.8B | 160M | 4.5B | 2.7B | 3.2B | — | — | — | — | 4.9B | 22.6B | 26.0% | — | 8.1% | — |
| 2025-12-31 | 34B | 13.1B | 6.9B | 10.4B | 5.1B | 5.3B | 3.8B | 164M | 4.6B | 2.8B | 2.9B | — | — | — | — | 5.1B | 28.1B | 27.2% | — | 7.2% | — |
LIN trades at 25.0x forward earnings against a peer median of 20.8x; EV/EBITDA of 18.6x against a peer median of 20.6x; 6 peers.
| Ecolab Inc. |
| 26.7x |
| 4.4x |
| 20.6x |
| 22.4% |
| 16.7% |
| APD | Air Products and Chemicals Inc. | 20.7x | 5.3x | 22.1x | 12.4% | 23.6% |
| PPG | PPG Industries Inc. | 12.6x | 1.5x | 11.3x | 20.7% | 13.7% |
| ALB | Albemarle Corporation | 20.8x | 4.5x | 36.4x | -4.7% | 2.3% |
